💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for Pacific Biosciences of California, Inc. (PACB)
« Back to company indexPACB Chatter Timeline
Stock Ticker for PACB
Most Active Tweeters for PACB
| User | Tweets |
|---|---|
| @dariussavelov | 10 |
| @mediasentiment | 9 |
| @newsfilterio | 8 |
| @BonusLevelFund | 7 |
| @supersingr1 | 6 |
Recent Tweets for PACB
 |
@MC_OptionTrades $PACB earnings move 6.4% vs an expected ±14.5% move https://t.co/vqvKswDanc 2:08am |
 |
@honkitchang $PACB big bullish outside day support at 200 day and powered thru 50 day. Short shelf pivot needs to be taken out at $32.49 if continue. 2:08am |
 |
@Shack_SI @reciknows Have a look at $PACB, one of it's holdings, almost identical chart and a very promising day today. 12:08am |
 |
@DeLevashov $PACB Idea: After earnings bouncing of 200MA -riding 200MA -price above all MA`s -possible range breakout over 32.1… https://t.co/uSTJzMDJYS 12:08am |
 |
@Adrian97707834 Don't forget your loss-cuts! BUYSIGN001 delivers performance trading $PACB through consistent loss-cuts execution.… https://t.co/GLp5aizx1X August 4th 2021, 11:08pm |
|
@Adrian97707834 Disapointed because of losses? What doesn't kill you makes you stronger! BUYSIGN001 has no emotions trading $PACB,… https://t.co/Crz53VGnyW August 4th 2021, 9:08pm |
 |
@FlynancialA $PACB 16% off LoD / 200 day SMA August 4th 2021, 8:08pm |
 |
@tmcgTTT $pacb pump fake August 4th 2021, 7:08pm |
 |
@dpmchale $PACB - dip at the open on earnings has now reversed to positive. 79% revenue growth. Another stock converging ne… https://t.co/RqSfbtKBTG August 4th 2021, 5:08pm |
 |
@dariussavelov @ALittle_gx Numbers looking really good! What do you think will drive $PACB for the next leg up? https://t.co/GYrP3q1nEW August 4th 2021, 5:08pm |
 |
@ALittle_gx (2/5) $PACB highlights: •2x installed base of Sequel 2 sequencing machines (increasing related downstream sales) •A… https://t.co/wuvCbVLVKF August 4th 2021, 4:08pm |
 |
@deadmau5mania $PACB big reversal off the 200SMA daily after earnings Cathie been adding to her position steadily and probably bought more today too August 4th 2021, 4:08pm |
|
@dariussavelov $PACB making higher lows and sitting on trend line. $40s incoming https://t.co/T82uLxGyiz August 4th 2021, 2:08pm |
 |
@Jarvis_Alerts $PACB [Pacific Biosciences]: Morgan Stanley Maintains Equal-Weight Lowers Price Target $45 --> 41 charts: courtesy… https://t.co/D4PEAZpohh August 4th 2021, 2:08pm |
|
@dariussavelov $PACB after every earnings call @GenomicsUK @joseph_cook1 https://t.co/FAs3m8KkHI August 4th 2021, 1:08pm |
 |
@EarningsAlley Pacific Biosciences of California, Inc. $PACB held an earnings call on 8/3/2021. Here are the highlights: August 4th 2021, 1:08pm |
 |
@naveenbioinfo RT @fwhealthtech: $PACB's latest buy also supplies to its biggest rival. https://t.co/mgvaGzUREA #MnA #nextgensequencing #genomics #bioin… August 4th 2021, 1:08pm |
 |
@quantisnow $PACB ? Morgan Stanley reiterated coverage on Pacific Biosciences with a new price target https://t.co/yjzk2nBRiq 30s delayed. August 4th 2021, 1:08pm |
 |
@fwhealthtech $PACB's latest buy also supplies to its biggest rival. https://t.co/mgvaGzUREA #MnA #nextgensequencing #genomics… https://t.co/bihDj452aX August 4th 2021, 12:08pm |
 |
@enghou $PACB - Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside https://t.co/2lqKcSPEGX August 4th 2021, 11:08am |
 |
@SeekingAlpha $PACB - Pacific Biosciences: Boom In Genome Sequencing Technology With 35% Upside. https://t.co/l9VIoRBuKO #finance #economy #investing August 4th 2021, 11:08am |
 |
@newsfilterio Pacific Biosciences Q2 Earnings Beat Expectations, Higher Operating Costs Widens Quarterly Loss $PACB https://t.co/SczmhzgxkQ August 4th 2021, 11:08am |
|
@newsfilterio Pacific Biosciences of California Announces Second Quarter 2021 Financial Results $PACB https://t.co/NabEcvmEsZ August 4th 2021, 7:08am |
|
@newsfilterio Pacific Biosciences of California EPS in-line, beats on revenue $PACB https://t.co/RPDLYEBLLx August 4th 2021, 6:08am |
 |
@SiteFocusHQ $PACB Earnings Intelligence Analysis of recent earnings identified Pacific Biosciences of California, Inc. (PACB) b… https://t.co/X55g7qMxyy August 4th 2021, 5:08am |
 |
@BradleySmita RT @joseph_cook1: $PACB growing consumable revenue from sequel 2/2e with several new customers August 4th 2021, 3:08am |
|
@SeekingAlpha $PACB - Pacific Biosciences of California, Inc. (PACB) CEO Christian Henry on Q2 2021 Results - Earnings Call Trans… https://t.co/uST14mOUlj August 4th 2021, 3:08am |
 |
@1upWallstreet Good buy $vuzi $Pacb https://t.co/jxMHVkZIbr August 4th 2021, 2:08am |
 |
@ThinkingChanged @NatHarooni @CRISPRinvest $ILMN over $PACB? ARK makes it seem like PACB is going to be the king of sequencing. August 4th 2021, 2:08am |
 |
@supersingr1 @PoundingDaTable $pacb just had a nice little acquisition & beat earnings. August 4th 2021, 2:08am |
 |
@LifetimeFinanc1 @NatHarooni $PACB Hifi & recent acquisitions don’t put it on the sequencing list? August 4th 2021, 12:08am |
 |
@tlgill23 I think $PACB would be higher on these results were it not for the Circulomics acquisition - nobody has had a chanc… https://t.co/i7lokOlprI August 3rd 2021, 11:08pm |
 |
@jjminich @BioMickWatson A way better purchase, I’ll probably buy $pacb on that deal August 3rd 2021, 11:08pm |
 |
@DNAed_tech RT @MedtechTinaTan: $PACB been hitting the M&A trail again. What's the likelihood of a THIRD acquisition round the corner? #genesequencing… August 3rd 2021, 10:08pm |
 |
@MedtechTinaTan $PACB been hitting the M&A trail again. What's the likelihood of a THIRD acquisition round the corner?… https://t.co/cMu80tsmf7 August 3rd 2021, 10:08pm |
|
@newsfilterio Pacific Biosciences posts revenue beat even as net loss widens amid rising SG&A expenses $PACB https://t.co/bJZVmJcFo5 August 3rd 2021, 9:08pm |
 |
@BonusLevelFund @teaze_r I support the $PACB mission and wish them the best, but, am a super hyped $BNGO bull haha.. I try my bes… https://t.co/coL75aR3Pw August 3rd 2021, 9:08pm |
 |
@teaze_r @BonusLevelFund Wow. I actually held some $PACB, but I sold it before earnings because last earnings was similar. T… https://t.co/vfAuLvRU09 August 3rd 2021, 9:08pm |
 |
@ShortAlgoTrades $PACB Awaiting Buy signal. Chart by UltraAlgo! https://t.co/aKQ1MJsKEH August 3rd 2021, 9:08pm |
|
@BonusLevelFund @salamanstl $PACB placed 38 Sequel II/IIe systems during q2 2021 compared to 23 Sequel II systems placed in the q2… https://t.co/tXQiZjDX9a August 3rd 2021, 9:08pm |
 |
@mehabecapital $PACB @ 30.21 - Pacific Biosciences posts revenue beat even as net loss widens amid rising SG&A expenses https://t.co/bOZU2GAfOU August 3rd 2021, 9:08pm |
 |
@ethanFlare $PACB - Pacific Biosciences posts revenue beat even as net loss widens amid rising SG&A expenses Cap size: mid, Flo… https://t.co/yx5jWfVXLJ August 3rd 2021, 9:08pm |
 |
@MarketCurrents $PACB - Pacific Biosciences posts revenue beat even as net loss widens amid rising SG&A expenses https://t.co/TSQ9nIaKV8 August 3rd 2021, 9:08pm |
|
@BonusLevelFund $PACB after earnings.. $29.50 -0.71 (-2.35%) After hours: 05:10PM EDT August 3rd 2021, 9:08pm |
 |
@suburbanaces RT @Estimize: The most accurate $PACB estimate is from @suburbanaces, beating 5 other analysts and the Wall Street Consensus - https://t.co… August 3rd 2021, 8:08pm |
 |
@MarcJacksonLA $PACB Pacific Biosciences of California, Inc. Announces Second Quarter 2021 Financial Results https://t.co/4mv2Tosq7x August 3rd 2021, 8:08pm |
 |
@joseph_cook1 $PACB growing consumable revenue from sequel 2/2e with several new customers August 3rd 2021, 8:08pm |
 |
@mediasentiment $PACB new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 1090 August 3rd 2021, 8:08pm |
|
@mehabecapital (Earnings) Pacific Biosciences ( $PACB ) Actual.EPS=-0.21 vs Est.EPS=-0.208, Actual.Rev=30.61M vs Est.Rev=29.8M, La… https://t.co/Vb5hMvlCmu August 3rd 2021, 8:08pm |
 |
@Estimize The most accurate $PACB estimate is from @suburbanaces, beating 5 other analysts and the Wall Street Consensus - https://t.co/WQHGyAFdrv August 3rd 2021, 8:08pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
DrugPatentWatch Video Training
Decision-making for generic drug entry and branded drug lifecycle management
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
This course answers the following questions to help you adapt:
- ✓ When will key drug patents expire?
- ✓ How can I find, evaluate, and plan for generic market entry opportunities?
- ✓ How can I find proprietary out-of-court settlements and deal terms?